NCT00193401View on ClinicalTrials.gov

Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

June 30, 2004

Study Completion Date

November 30, 2004

Conditions
Lung Cancer
Interventions
DRUG

Topotecan

All Listed Sponsors
collaborator

Institutional Review Board TriStar Nashville Market

UNKNOWN

lead

SCRI Development Innovations, LLC

OTHER

NCT00193401 - Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter